Utira-C (Mission Pharmacal Company)
Welcome to the PulseAid listing for the Utira-C drug offered from Mission Pharmacal Company. This Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mission Pharmacal Company |
| NON-PROPRIETARY NAME: | methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue, hyoscyamine sulfate |
| SUBSTANCE NAME: | METHENAMINE; SODIUM PHOSPHATE, MONOBASIC; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2011-09-11 |
| END MARKETING DATE: | 0000-00-00 |
Utira-C HUMAN PRESCRIPTION DRUG Details:
| Item Description | Utira-C from Mission Pharmacal Company |
| LABELER NAME: | Mission Pharmacal Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 81.6; 40.8; 36.2; 10.8; .12(mg/1; mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2011-09-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0178-0513_05e900d7-3b87-4166-b213-b9e26c65ff14 |
| PRODUCT NDC: | 0178-0513 |
| APPLICATION NUMBER: | |
Other METHENAMINE; SODIUM PHOSPHATE, MONOBASIC; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE Pharmaceutical Manufacturers / Labelers:
